MedTrace Logo

Evaluation of Implantable Tibial Neuromodulation (TITAN 1) Feasibility Study

NCT04873271 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2022-07-13

No results posted yet for this study

Summary

This is a prospective, multicenter, feasibility study to characterize the procedure for the implantable TNM device in subjects with overactive bladder.

Conditions

Interventions

DEVICE

Medtronic Implantable Tibial Neuromodulation (TNM) System

Tibial neuromodulation (TNM) devices are implantable devices that provide stimulation to the tibial nerve.

Sponsors & Collaborators

  • MedtronicNeuro

    lead INDUSTRY

Principal Investigators

  • Anne Miller · Medtronic

Study Design

Allocation
NA
Purpose
DEVICE_FEASIBILITY
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-05-11
Primary Completion
2021-08-04
Completion
2022-07-08
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04873271 on ClinicalTrials.gov